Sign inGet started

Thompson Craig B.

Insider CIK 1423419 · CRL Director · MRK Director · REGN Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CRL CHARLES RIVER LABORATORIES A Award2026-05-082026-05-121,438$177.62 $255.4K3,851SEC↗
REGN REGENERON PHARMACEUTICALS, A Award deriv2026-01-022026-01-061,962— $01,962SEC↗
REGN REGENERON PHARMACEUTICALS, A Award2026-01-022026-01-06155— $0775SEC↗
CRL CHARLES RIVER LABORATORIES A Award deriv2025-05-212025-05-232,076$134.98 $280.2K2,076SEC↗
CRL CHARLES RIVER LABORATORIES A Award2025-05-212025-05-23946$134.98 $127.7K2,413SEC↗
REGN REGENERON PHARMACEUTICALS, A Award deriv2025-01-022025-01-061,958— $01,958SEC↗
REGN REGENERON PHARMACEUTICALS, A Award2025-01-022025-01-06166— $0620SEC↗
CRL CHARLES RIVER LABORATORIES A Award deriv2024-05-132024-05-151,311$228.41 $299.4K1,311SEC↗
CRL CHARLES RIVER LABORATORIES A Award2024-05-132024-05-15559$228.41 $127.7K1,467SEC↗
REGN REGENERON PHARMACEUTICALS, A Award deriv2024-01-022024-01-041,607— $01,607SEC↗
REGN REGENERON PHARMACEUTICALS, A Award2024-01-022024-01-04135— $0454SEC↗
CRL CHARLES RIVER LABORATORIES A Award deriv2023-05-152023-05-171,669$192.36 $321.0K1,669SEC↗
CRL CHARLES RIVER LABORATORIES A Award2023-05-152023-05-17664— $0908SEC↗
CRL CHARLES RIVER LABORATORIES A Award deriv2023-01-032023-01-04592$218.40 $129.3K592SEC↗
REGN REGENERON PHARMACEUTICALS, A Award deriv2023-01-032023-01-05477— $0477SEC↗
CRL CHARLES RIVER LABORATORIES A Award2023-01-032023-01-04244— $0244SEC↗
REGN REGENERON PHARMACEUTICALS, A Award2023-01-032023-01-0540— $0319SEC↗
REGN REGENERON PHARMACEUTICALS, A Award deriv2022-10-032022-10-053,216— $03,216SEC↗
REGN REGENERON PHARMACEUTICALS, A Award2022-10-032022-10-05279— $0279SEC↗
MRK Merck & Co., Inc. A Award deriv2018-05-252018-05-293,131$59.09 $185.0K31,810SEC↗
CRL CHARLES RIVER LABORATORIES A Award2018-05-142018-05-152,004— $016,933SEC↗
CRL CHARLES RIVER LABORATORIES A Award2018-05-142018-05-15653— $017,586SEC↗
MRK Merck & Co., Inc. A Award deriv2017-05-262017-05-302,619$64.92 $170.0K27,773SEC↗
CRL CHARLES RIVER LABORATORIES A Award2017-05-122017-05-16793— $014,929SEC↗
CRL CHARLES RIVER LABORATORIES A Award2017-05-122017-05-162,436— $014,136SEC↗
MRK Merck & Co., Inc. A Award deriv2016-05-272016-05-313,010$56.48 $170.0K24,409SEC↗
CRL CHARLES RIVER LABORATORIES A Award2016-05-122016-05-16850— $011,700SEC↗
CRL CHARLES RIVER LABORATORIES A Award2016-05-122016-05-162,260— $010,850SEC↗
MRK Merck & Co., Inc. A Award deriv2015-05-292015-06-012,463$60.89 $150.0K20,687SEC↗
CRL CHARLES RIVER LABORATORIES A Award deriv2015-05-062015-05-083,140— $03,140SEC↗
CRL CHARLES RIVER LABORATORIES A Award2015-05-062015-05-081,970— $08,590SEC↗
MRK Merck & Co. Inc. A Award deriv2014-05-302014-06-032,592$57.86 $150.0K17,684SEC↗
CRL CHARLES RIVER LABORATORIES A Award deriv2014-05-072014-05-093,530— $03,530SEC↗
CRL CHARLES RIVER LABORATORIES A Award2014-05-072014-05-092,720— $06,620SEC↗
CRL CHARLES RIVER LABORATORIES A Award deriv2014-01-022014-01-065,120— $05,120SEC↗
CRL CHARLES RIVER LABORATORIES A Award2014-01-022014-01-063,900— $03,900SEC↗
MRK Merck & Co. Inc. A Award deriv2013-05-312013-06-033,212$46.70 $150.0K14,577SEC↗
MRK Merck & Co. Inc. A Award deriv2012-05-252012-05-293,995$37.55 $150.0K10,935SEC↗